These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6755560)

  • 1. The value of cytidine-5-diphosphate-choline in the prevention of impairment of memory function after electric convulsive therapy. A double-blind study.
    Ayuso-Gutierrez JL; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):243-8. PubMed ID: 6755560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDP-choline for the treatment of tardive dyskinesia: a small negative series.
    Gelenberg AJ; Wojcik J; Falk WE; Bellinghausen B; Joseph AB
    Compr Psychiatry; 1989; 30(1):1-4. PubMed ID: 2647398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of CDP-choline on poststroke hemiplegia employing a double-blind controlled trial. Assessed by a new rating scale for recovery in hemiplegia.
    Hazama T; Hasegawa T; Ueda S; Sakuma A
    Int J Neurosci; 1980; 11(3):211-25. PubMed ID: 7002829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 5. Does piracetam counteract the ECT-induced memory dysfunctions in depressed patients?
    Mindus P; Cronholm B; Levander SE
    Acta Psychiatr Scand; 1975 Jun; 51(5):319-26. PubMed ID: 1096538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
    Tazaki Y; Sakai F; Otomo E; Kutsuzawa T; Kameyama M; Omae T; Fujishima M; Sakuma A
    Stroke; 1988 Feb; 19(2):211-6. PubMed ID: 3278412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autobiographical and subjective memory with right unilateral high-dose 0.3-millisecond ultrabrief-pulse and 1-millisecond brief-pulse electroconvulsive therapy: a double-blind, randomized controlled trial.
    Mayur P; Byth K; Harris A
    J ECT; 2013 Dec; 29(4):277-82. PubMed ID: 24263273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia.
    Stryjer R; Ophir D; Bar F; Spivak B; Weizman A; Strous RD
    Clin Neuropharmacol; 2012; 35(4):161-4. PubMed ID: 22751086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive training to improve memory in individuals undergoing electroconvulsive therapy: Negative findings.
    Choi J; Wang Y; Feng T; Prudic J
    J Psychiatr Res; 2017 Sep; 92():8-14. PubMed ID: 28376409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary CDP-choline supplementation prevents memory impairment caused by impoverished environmental conditions in rats.
    Teather LA; Wurtman RJ
    Learn Mem; 2005; 12(1):39-43. PubMed ID: 15647594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing bilateral to unilateral electroconvulsive therapy in a randomized study with EEG monitoring.
    Horne RL; Pettinati HM; Sugerman AA; Varga E
    Arch Gen Psychiatry; 1985 Nov; 42(11):1087-92. PubMed ID: 3901956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of piracetam on ECT-induced cognitive disturbances: a randomized, placebo-controlled, double-blind study.
    Tang WK; Ungvari GS; Leung HC
    J ECT; 2002 Sep; 18(3):130-7. PubMed ID: 12394531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome].
    Valls i Soler A; Sanjurjo P; Vázquez Cordero C
    An Esp Pediatr; 1988 Jun; 28(6):493-6. PubMed ID: 3195851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment.
    Salvadorini F; Galeone F; Nicotera M; Ombrato M; Saba P
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):513-20. PubMed ID: 810312
    [No Abstract]   [Full Text] [Related]  

  • 19. Dietary cytidine (5')-diphosphocholine supplementation protects against development of memory deficits in aging rats.
    Teather LA; Wurtman RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):711-7. PubMed ID: 12787861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.